Advanced Search

    Technical Analysis for PPCBD - Propanc Biopharma Inc

    Grade Last Price % Change Price Change
    C 0.0500 84.50% 0.0229
    PPCBD closed up 84.5 percent on Friday, June 2, 2023, on 65 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent N/A N/A N/A
    Historical PPCBD trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Gapped Up Strength 0.00%
    New 52 Week Closing Low Bearish 84.50%
    Gapped Up Strength 84.50%
    Down 3 Days in a Row Weakness 84.50%
    Down 4 Days in a Row Weakness 84.50%
    New 52 Week Closing Low Bearish 0.81%
    Hot IPO Pullback Bullish Swing Setup 0.81%
    Doji - Bullish? Reversal 0.81%
    Older End-of-Day Signals for PPCBD ...

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    PPCBD Chart by TradingView
    Basic chart:

    Profile

    Propanc Biopharma, Inc., a development-stage healthcare company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug discovery program. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was founded in 2007 and is based in Camberwell, Australia.
    Classification
    Keywords: Health Biotechnology Healthcare Cancer Life Sciences Drug Discovery Colorectal Cancer Monoclonal Antibodies Sarepta Therapeutics University Of Jaén

    Is PPCBD a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 0 bearish and 5 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.2
    52 Week Low 0.02
    Average Volume 152,757
    200-Day Moving Average 0.0000
    50-Day Moving Average 0.0000
    20-Day Moving Average 0.0000
    10-Day Moving Average 0.0000
    Average True Range 0.0000
    RSI (14) 0.00
    ADX 0.0
    +DI 0.0000
    -DI 0.0000
    Chandelier Exit (Long, 3 ATRs) N/A
    Chandelier Exit (Short, 3 ATRs) N/A
    Upper Bollinger Bands 0.0000
    Lower Bollinger Band 0.0000
    Percent B (%b) 0.0
    BandWidth 0.0000
    MACD Line 0.0000
    MACD Signal Line 0.0000
    MACD Histogram 0.0
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.0799
    Resistance 3 (R3) 0.0765 0.0633 0.0749
    Resistance 2 (R2) 0.0633 0.0557 0.0649 0.0732
    Resistance 1 (R1) 0.0566 0.0510 0.0600 0.0600 0.0716
    Pivot Point 0.0434 0.0434 0.0450 0.0450 0.0434
    Support 1 (S1) 0.0367 0.0358 0.0401 0.0401 0.0284
    Support 2 (S2) 0.0235 0.0311 0.0251 0.0268
    Support 3 (S3) 0.0168 0.0235 0.0251
    Support 4 (S4) 0.0202